Skip to main content

Table 3 Performance of the various criteria currently in use to define metabolic health to predict insulin resistance, defined as Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) ≥2.5

From: Prevalence rates of metabolic health and body size phenotypes by different criteria and association with insulin resistance in a Maltese Caucasian population

Males
  Crude Odds Ratio (value) Odds Ratio (value) adjusted for BMI
NCEP-0 9.4 (p = 0.03) 6.1 (p = 0.017)
NCEP-1 10.2 (p < 0.001) 7.8 (p < 0.001)
NCEP-2 13.1 (p < 0.001) 10.2 (p < 0.001)
Doumatey et al. 12.2 (p < 0.001) 10.5 (p < 0.001)
Hamer et al. 10.1 (p < 0.001) 7.7 (p < 0.001)
Lynch et al. 16.6 (p < 0.001) 13.7 (p < 0.001)
Aguilar-Salinas et al. 18.7 (p < 0.001) 15.3 (p < 0.001)
Harmonisation criteria (Lavie et al.) 12.1 (p = 0.001) 9.1 (p = 0.003)
Females
NCEP-0 3.6 (p = 0.002) 1.8 (p = 0.22)
NCEP-1 8.3 (p < 0.001) 5.7 (p < 0.001)
NCEP-2 19.7(p < 0.001) 16.1 (p < 0.001)
Doumatey et al. 2.6 (p = 0.003) 2.4 (p = 0.008)
Hamer et al. 4.9 (p < 0.001) 2.9 (p = 0.008)
Lynch et al. 4.8 (p < 0.001) 3.2 (p = 0.001)
Aguilar-Salinas et al. 2.7 (p = 0.002) 2.3 (p = 0.014)
Harmonisation criteria (Lavie et al.) 5.7 (p < 0.001) 3.6 (p = 0.001)
  1. NCEP National Cholesterol Education Program/Adult Treatment Panel III